Company
Headquarters: Taipei, Taiwan
TW$3.45 Billion
TWD as of July 1, 2024
US$105.9 Million
Company | Market Cap (USD) |
---|---|
Abbott | $178.02 B |
Stryker Corporation | $126.48 B |
Boston Scientific Corporation | $112.32 B |
Medtronic | $98.95 B |
Edwards Lifesciences Corporation | $55.63 B |
Company | Market Cap (USD) |
---|---|
Lilly | $808.65 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $450.89 B |
Johnson & Johnson | $350.63 B |
Merck | $318.75 B |
Diamond Biotechnology Co., Ltd engages in the research, development, manufacture, and sale of medical equipment and consumables. It offers medical beauty-level skin care products. The company also provides medical beauty management consultancy services. Its customers include hospitals, clinics, and open channels primarily in Taiwan. The company was founded in 2014 and is based in Taipei, Taiwan.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Diamond Biotechnology Co. Ltd has the following listings and related stock indices.
Stock: TWSE: 6815 wb_incandescent